Opioid Addiction
- All
- News
- Videos
-
Yoga Aids Speedy Opioid Withdrawal Recovery, Improves Anxiety, Sleep: Study
Yoga can aid in the speedy recovery of people with opioid withdrawal, as well as improve anxiety, sleep, and pain in them, according to a study.
-
Migrant With 42 Convictions To Stay In UK After Judge Says He Would 'Struggle Mentally'
The drug-addled migrant has been living in the UK since the age of six but has had a prolific crime career.
-
India Bans Two Addictive Opioids Amid Misuse In West Africa
The drugs were being illegally exported to West African countries by Mumbai-based Aveo Pharmaceuticals
-
FDA Approves Suzetrigine, First Non-Opioid Painkiller in Decades
The FDA has approved suzetrigine, a groundbreaking painkiller that blocks sodium channels to provide opioid-level pain relief without the risks of addiction, sedation, or overdose. Known as Journavx, this drug is the first in over two decades to introduce a new pain relief mechanism. Clinical trials showed it matched opioids in effectiveness but wi...
-
Failure of AstraZeneca Trial Big Blow For Anti-Addiction Drugs: Report
The failure of the trial of the drug AZD4041 by pharma giant AstraZeneca, to combat opioid use disorder (OUD), highlights the challenges in developing non-opioid medications that treat addiction and withdrawal, according to a report.
-
Placebo Effect Link Discovered With Previously Unassociated Parts of the Brain
Patients suffering from chronic pain have limited treatment options, often relying on medications like opioids that come with harmful side effects and high addiction risks. A new study in mice, published in Current Biology journal, suggests a new way to use the placebo effect for treating chronic pain. By activating specific neurons in the brain li...
-
Indian-American Gitanjali Rao, 15, First-Ever TIME "Kid Of The Year"
15-year-old Indian-American Gitanjali Rao, a "brilliant" young scientist and inventor, has been named by TIME magazine as the first-ever 'Kid of the Year' for her "astonishing work" using technology to tackle issues ranging from contaminated drinking water to opioid addiction and cyberbullying.
-
Indian-Origin Doctor Faces 20 Years In Jail For Writing Illegal Medicines
An Indian-origin doctor pleaded guilty to illegally giving controlled substances to six patients, including one who suffered from opioid addiction and later died of a drug overdose.Gurpreet Singh Bajwa, 49 of Fairfax, Virginia temporarily lost his medical license in 2012 following an investigation by the Virginia Department of Health Professions (D...
-
Johnson & Johnson Reaches $20.4 Million Settlement Ahead Of Opioid Trial
US healthcare giant Johnson & Johnson on Tuesday announced it had reached a $20.4 million settlement to avoid a much-anticipated trial in Ohio for allegedly fueling the opioid addiction crisis.
-
Johnson & Johnson Verdict Sends Opioid Makers A Billion-Dollar Warning
The US pharmaceutical industry faces tens of billions of dollars in potential damage payments for fueling the opioid addiction crisis after Oklahoma won a $572 million judgment against drugmaker Johnson & Johnson.
-
Yoga Aids Speedy Opioid Withdrawal Recovery, Improves Anxiety, Sleep: Study
Yoga can aid in the speedy recovery of people with opioid withdrawal, as well as improve anxiety, sleep, and pain in them, according to a study.
-
Migrant With 42 Convictions To Stay In UK After Judge Says He Would 'Struggle Mentally'
The drug-addled migrant has been living in the UK since the age of six but has had a prolific crime career.
-
India Bans Two Addictive Opioids Amid Misuse In West Africa
The drugs were being illegally exported to West African countries by Mumbai-based Aveo Pharmaceuticals
-
FDA Approves Suzetrigine, First Non-Opioid Painkiller in Decades
The FDA has approved suzetrigine, a groundbreaking painkiller that blocks sodium channels to provide opioid-level pain relief without the risks of addiction, sedation, or overdose. Known as Journavx, this drug is the first in over two decades to introduce a new pain relief mechanism. Clinical trials showed it matched opioids in effectiveness but wi...
-
Failure of AstraZeneca Trial Big Blow For Anti-Addiction Drugs: Report
The failure of the trial of the drug AZD4041 by pharma giant AstraZeneca, to combat opioid use disorder (OUD), highlights the challenges in developing non-opioid medications that treat addiction and withdrawal, according to a report.
-
Placebo Effect Link Discovered With Previously Unassociated Parts of the Brain
Patients suffering from chronic pain have limited treatment options, often relying on medications like opioids that come with harmful side effects and high addiction risks. A new study in mice, published in Current Biology journal, suggests a new way to use the placebo effect for treating chronic pain. By activating specific neurons in the brain li...
-
Indian-American Gitanjali Rao, 15, First-Ever TIME "Kid Of The Year"
15-year-old Indian-American Gitanjali Rao, a "brilliant" young scientist and inventor, has been named by TIME magazine as the first-ever 'Kid of the Year' for her "astonishing work" using technology to tackle issues ranging from contaminated drinking water to opioid addiction and cyberbullying.
-
Indian-Origin Doctor Faces 20 Years In Jail For Writing Illegal Medicines
An Indian-origin doctor pleaded guilty to illegally giving controlled substances to six patients, including one who suffered from opioid addiction and later died of a drug overdose.Gurpreet Singh Bajwa, 49 of Fairfax, Virginia temporarily lost his medical license in 2012 following an investigation by the Virginia Department of Health Professions (D...
-
Johnson & Johnson Reaches $20.4 Million Settlement Ahead Of Opioid Trial
US healthcare giant Johnson & Johnson on Tuesday announced it had reached a $20.4 million settlement to avoid a much-anticipated trial in Ohio for allegedly fueling the opioid addiction crisis.
-
Johnson & Johnson Verdict Sends Opioid Makers A Billion-Dollar Warning
The US pharmaceutical industry faces tens of billions of dollars in potential damage payments for fueling the opioid addiction crisis after Oklahoma won a $572 million judgment against drugmaker Johnson & Johnson.
